Unequal at the Counter: The Research on Racial Disparities in Pharmacy Services and What Patients Can Do About It

For most Americans, the pharmacy counter is a routine fixture of healthcare—a stop between the doctor's office and home. But for a significant portion of the population, that counter represents something more fraught: a site where race, zip code, and socioeconomic status can quietly determine whether a prescription is filled, how thoroughly it is explained, and how long the wait will be.

This is not anecdote. It is documented in peer-reviewed research, federal health data, and investigative reporting spanning more than two decades. TabOrderRx is committed to providing all patients with accurate health information, and that commitment requires addressing this subject directly.

What the Research Shows

The evidence of racial and socioeconomic disparities in pharmacy services is substantial and spans multiple dimensions of care.

Controlled substance access. A landmark 2000 study published in the Journal of the American Medical Association found that pharmacies in predominantly nonwhite neighborhoods were significantly less likely to stock adequate supplies of opioid pain medications than pharmacies in predominantly white neighborhoods—even when controlling for population density and other variables. A follow-up study in 2012 found the disparity had not meaningfully improved. Patients with legitimate prescriptions for pain management were effectively unable to fill them based on where they lived.

Prescription refusal rates. Research examining pharmacist refusal patterns has found that Black and Hispanic patients are more likely to experience refusals or requests for additional verification when presenting prescriptions for controlled substances, even when those prescriptions are valid and properly documented. A 2021 study in JAMA Network Open documented that pharmacists were more likely to question the legitimacy of prescriptions presented by patients of color.

Counseling disparities. Federal law requires pharmacists to offer counseling on new prescriptions. Studies have found that this offer is extended less consistently to Black and Hispanic patients than to white patients, and that when counseling is provided, it is often shorter and less thorough. Given that medication counseling is one of the primary mechanisms by which patients learn to take medications correctly and recognize dangerous side effects, this disparity has direct clinical consequences.

Geographic access. Research published in Health Affairs and elsewhere has documented a consistent pattern of pharmacy deserts in predominantly Black and low-income urban neighborhoods. When the nearest pharmacy is miles away or accessible only by unreliable public transit, the barriers to filling and refilling prescriptions become structural rather than merely logistical.

The Mechanisms Behind Disparate Treatment

Understanding why these disparities exist requires looking beyond individual pharmacist behavior—though individual behavior is a component—to the structural factors that shape pharmacy care.

Implicit bias. Research in healthcare settings broadly has demonstrated that implicit racial bias influences clinical decision-making in ways that practitioners are often unaware of. Pharmacists, like physicians and nurses, are not immune to these cognitive patterns. Studies using implicit association tests have found measurable bias among healthcare providers across racial lines, and there is no reason to assume pharmacy practice is exempt.

Inventory decisions driven by profit. The decision about which medications to stock in which quantities is made at the corporate or store level, often based on historical dispensing patterns and projected profitability. In neighborhoods where patients are more likely to be uninsured or underinsured, lower reimbursement rates may discourage robust inventory of certain drug classes. This creates a feedback loop in which underserved communities receive less access, which produces lower dispensing volumes, which justifies continued underinvestment.

Staffing and service quality. Pharmacies in lower-income neighborhoods are frequently understaffed relative to their prescription volume. When pharmacists are managing excessive workloads, the quality of every interaction suffers—but counseling, which requires time and attention, is among the first services to be curtailed. Patients in these settings receive less information not necessarily because of intentional discrimination but because the system is not resourced to provide adequate care.

Policing and suspicion. In communities subject to heightened law enforcement scrutiny, some pharmacists have internalized a posture of suspicion toward patients presenting prescriptions for controlled substances. While diversion and fraud are legitimate concerns in pharmacy practice, the application of that suspicion is not racially neutral. Patients who are Black or Hispanic report being asked to provide additional identification, questioned about the legitimacy of their prescriptions, or made to feel presumptively dishonest at rates that white patients do not describe.

Patient Experiences

Behind the statistics are individual encounters that accumulate into a pattern of diminished trust in the healthcare system. Patients have described being told a medication is out of stock—only to see it dispensed to the next customer. Others report being asked to wait in a separate area while prescriptions are "verified," a request not made of other patients. Some describe receiving no counseling at all on new medications, leaving them to navigate side effects and dosing instructions without guidance.

These experiences are not uniform, and many patients of color receive excellent, attentive pharmacy care. But the documented pattern is consistent enough to warrant systematic attention rather than dismissal as isolated incidents.

What Patients Can Do

Knowledge of this problem does not eliminate it, but it can help patients navigate more effectively and advocate for the care they are entitled to receive.

Document specific incidents. If you believe you have been treated differently than other patients in a pharmacy setting—denied a prescription without clear justification, refused standard counseling, or subjected to verification requests not applied to others—document the date, time, location, pharmacist's name if available, and a factual account of what occurred. This documentation is essential if you choose to file a complaint.

File a formal complaint. Complaints about discriminatory pharmacy practices can be filed with your state board of pharmacy, the pharmacy chain's corporate compliance office, and the U.S. Department of Health and Human Services Office for Civil Rights. Federal law prohibits discrimination in healthcare settings receiving federal funding, which includes virtually every pharmacy participating in Medicare or Medicaid.

Request your state's patient rights information. Every state pharmacy practice act includes provisions governing patient rights. Pharmacists are required to provide written information about these rights upon request in most jurisdictions.

Consider mail-order and online pharmacy services. Digital pharmacy platforms can reduce exposure to in-person bias by processing prescriptions through standardized, documented workflows. Services like TabOrderRx operate under federal and state pharmacy regulations and provide a consistent, auditable record of every transaction.

Ask for a transfer. If you consistently receive poor service at a particular pharmacy, you are entitled to transfer your prescriptions to another provider. You do not owe loyalty to a pharmacy that does not serve you equitably.

Engage your prescriber. If you are experiencing difficulty filling a prescription, inform your physician or nurse practitioner. They can contact the pharmacy directly, provide additional documentation, or recommend alternative dispensing options.

The Systemic Response Required

Individual strategies matter, but they do not substitute for systemic change. Pharmacy chains, state boards of pharmacy, and federal regulators all have roles to play in addressing documented disparities.

Some pharmacy chains have begun implementing implicit bias training for staff. State boards of pharmacy can and should incorporate equity metrics into their oversight frameworks. Federal programs that address pharmacy deserts through targeted investment in underserved communities have existed in limited form and warrant expansion.

The pharmacy counter is, for many Americans, the most frequent point of contact with the formal healthcare system. What happens there—whether patients are treated with dignity, given accurate information, and provided consistent access to their medications—shapes health outcomes in ways that extend far beyond any single prescription.

Equitable pharmacy care is not a supplement to good healthcare. It is a precondition for it.